Cardiopulmonary Stress Testing Devices Market by Application (Exercise Tolerance Testing Devices, Echocardiograph Testing Devices, Nuclear Stress Testing Devices), Product (Exercise Stress Testing Devices and Pharmacological Stress Testing Devices), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global cardiopulmonary stress testing devices market size is expected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing incidence of cardiovascular and pulmonary disorders including arrhythmia and heart valve imbalance.
Cardiopulmonary stress testing is used to assess exercise ability and predict outcome in patients with heart failure. It is a non-invasive, highly adaptive stress examination that assesses the cardiovascular, pulmonary, neurophysiological, hematopoietic, and skeletal muscle systems' responses to exercise. Ischemic heart disease, heart failure, shortness of breath, asthma, and other lung diseases can also be detected with cardiopulmonary stress monitoring. The main aim of cardiac stress testing is to determine coronary artery disease (CAD) risk stratification, which is one of the leading causes of death worldwide. It's a disease that causes blood vessels in the arteries that supply blood to the heart muscles to get clogged.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing lifestyle disorders as well as disorder related to heart and lungs are projected to propel the market growth in the forecast period.
- Increasing geriatric population in developed countries such as U.S., the U.K., and Japan. Brazil, China, Thailand, and South Korea is expected to drive the market growth during the forecast period.
- Increasing advancement in cardiopulmonary stress testing systems is resulting in more accurate and reliable results is estimated to boost the market growth.
- High cost of cardiopulmonary stress test system is estimated to hinder the market growth.
- Increased R&D investment by private and public organizations for technological advancement is expected to offer lucrative opportunities for the market players.
Scope of the Report
The report on the global cardiopulmonary stress testing includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Cardiopulmonary Stress Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Application (Exercise Tolerance Testing Devices, Echocardiograph Testing Devices, Nuclear Stress Testing Devices), Product (Exercise Stress Testing Devices and Pharmacological Stress Testing Devices) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Thermo Fisher Scientific Ltd; Philips Healthcare; Care Medical Ltd; Cosmed Medical; Cardiac Science Corporation; GE Healthcare; TouchPoint; Cardinal Health; NIHON KOHDEN CORPORATION; Vyaire Medical Inc.; W.L. Gore & Associates |
Market Segment Insights
The exercise tolerance testing devices segment is expected to account for a key share of the market
Based on application, the cardiopulmonary stress testing market is segmented into exercise tolerance testing devices, echocardiograph testing devices, nuclear stress testing devices. The exercise tolerance testing devices segment is expected to account for a key share of the market during the forecast period owing to the accuracy and the least operating by these devices. Also, exercise tolerance testing devices are cost effective and has multiple use is another factor that is expected to propel the market growth.
The pharmacological stress testing device segment is expected to constitute a key share of the market
Based on product, the cardiopulmonary stress testing market is bifurcated into Exercise Stress Testing Devices and Pharmacological Stress Testing Devices. The pharmacological stress testing device segment is expected to constitute a key share of the market during the forecast period due to the increasing geriatric population with decreased functional capacity.
North America is anticipated to dominate the market
On the basis of regions, the cardiopulmonary stress testing is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at an impressive CAGR during the forecast period. The regional market growth can be attributed to increased awareness about the advantages of cardiopulmonary stress testing amongst medical professionals.
On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increased prevalence of cardiovascular and pulmonary diseases in the region. Worldwide, high levels of air pollution have resulted in an unprecedented rise in respiratory and cardiovascular diseases.
Segments
Segments Covered in the ReportThe global cardiopulmonary stress testing market has been segmented on the basis of
Application
- Exercise Tolerance Testing Devices
- Echocardiograph Testing Devices
- Nuclear Stress Testing Devices
- Exercise Stress Testing Devices
- Pharmacological Stress Testing Devices
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Thermo Fisher Scientific Ltd
- Philips Healthcare
- Care Medical Ltd
- Cosmed Medical
- Cardiac Science Corporation
- GE Healthcare
- TouchPoint
- Cardinal Health
- NIHON KOHDEN CORPORATION
- Vyaire Medical Inc.
- W.L. Gore & Associates
Competitive Landscape
Key players competing in the cardiopulmonary stress testing market are Thermo Fisher Scientific Ltd; Philips Healthcare; Care Medical Ltd; Cosmed Medical; Cardiac Science Corporation; GE Healthcare; TouchPoint; Cardinal Health; NIHON KOHDEN CORPORATION; Vyaire Medical Inc.; W.L. Gore & Associates.
Few of the industry's key players in the market are aggressively acquiring other firms to strengthen their market positions across the world, while some are introducing new products. Vyaire Medical Inc, for example, received FDA approval in August 2019 for its two Novel Pulmonary Function Testing Products, Vyntus ONE and Vyntus BODY, which extended their current Vyntus product line, which runs on the SentrySuite Software. The approved products offer a new ergonomic design as well as reliable and effective respiratory monitoring. The companies in the cardiopulmonary stress testing market are facing moderate level of competition.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiopulmonary Stress Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiopulmonary Stress Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiopulmonary Stress Testing Market - Supply Chain
4.5. Global Cardiopulmonary Stress Testing Market Forecast
4.5.1. Cardiopulmonary Stress Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiopulmonary Stress Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cardiopulmonary Stress Testing Market Absolute $ Opportunity
5. Global Cardiopulmonary Stress Testing Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
5.3.1. Exercise Tolerance Testing Devices
5.3.2. Echocardiograph Testing Devices
5.3.3. Nuclear Stress Testing Devices
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Cardiopulmonary Stress Testing Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Cardiopulmonary Stress Testing Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
7. North America Cardiopulmonary Stress Testing Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
7.4.1. Exercise Tolerance Testing Devices
7.4.2. Echocardiograph Testing Devices
7.4.3. Nuclear Stress Testing Devices
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
8. Latin America Cardiopulmonary Stress Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
8.4.1. Exercise Tolerance Testing Devices
8.4.2. Echocardiograph Testing Devices
8.4.3. Nuclear Stress Testing Devices
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
9. Europe Cardiopulmonary Stress Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
9.4.1. Exercise Tolerance Testing Devices
9.4.2. Echocardiograph Testing Devices
9.4.3. Nuclear Stress Testing Devices
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Cardiopulmonary Stress Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
10.4.1. Exercise Tolerance Testing Devices
10.4.2. Echocardiograph Testing Devices
10.4.3. Nuclear Stress Testing Devices
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Cardiopulmonary Stress Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
11.4.1. Exercise Tolerance Testing Devices
11.4.2. Echocardiograph Testing Devices
11.4.3. Nuclear Stress Testing Devices
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Cardiopulmonary Stress Testing Market: Market Share Analysis
12.2. Cardiopulmonary Stress Testing Distributors and Customers
12.3. Cardiopulmonary Stress Testing Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Thermo Fisher Scientific Ltd
12.4.2. Philips Healthcare
12.4.3. Care Medical Ltd
12.4.4. Cosmed Medical
12.4.5. Cardiac Science Corporation
12.4.6. GE Healthcare
12.4.7. TouchPoint
12.4.8. Cardinal Health
12.4.9. NIHON KOHDEN CORPORATION
12.4.10. Vyaire Medical Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiopulmonary Stress Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiopulmonary Stress Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiopulmonary Stress Testing Market - Supply Chain
4.5. Global Cardiopulmonary Stress Testing Market Forecast
4.5.1. Cardiopulmonary Stress Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiopulmonary Stress Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cardiopulmonary Stress Testing Market Absolute $ Opportunity
5. Global Cardiopulmonary Stress Testing Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
5.3.1. Exercise Tolerance Testing Devices
5.3.2. Echocardiograph Testing Devices
5.3.3. Nuclear Stress Testing Devices
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Cardiopulmonary Stress Testing Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Cardiopulmonary Stress Testing Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
7. North America Cardiopulmonary Stress Testing Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
7.4.1. Exercise Tolerance Testing Devices
7.4.2. Echocardiograph Testing Devices
7.4.3. Nuclear Stress Testing Devices
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
8. Latin America Cardiopulmonary Stress Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
8.4.1. Exercise Tolerance Testing Devices
8.4.2. Echocardiograph Testing Devices
8.4.3. Nuclear Stress Testing Devices
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
9. Europe Cardiopulmonary Stress Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
9.4.1. Exercise Tolerance Testing Devices
9.4.2. Echocardiograph Testing Devices
9.4.3. Nuclear Stress Testing Devices
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Cardiopulmonary Stress Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
10.4.1. Exercise Tolerance Testing Devices
10.4.2. Echocardiograph Testing Devices
10.4.3. Nuclear Stress Testing Devices
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Cardiopulmonary Stress Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Cardiopulmonary Stress Testing Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Cardiopulmonary Stress Testing Market Size and Volume Forecast by Applications
11.4.1. Exercise Tolerance Testing Devices
11.4.2. Echocardiograph Testing Devices
11.4.3. Nuclear Stress Testing Devices
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Cardiopulmonary Stress Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Cardiopulmonary Stress Testing Market: Market Share Analysis
12.2. Cardiopulmonary Stress Testing Distributors and Customers
12.3. Cardiopulmonary Stress Testing Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Thermo Fisher Scientific Ltd
12.4.2. Philips Healthcare
12.4.3. Care Medical Ltd
12.4.4. Cosmed Medical
12.4.5. Cardiac Science Corporation
12.4.6. GE Healthcare
12.4.7. TouchPoint
12.4.8. Cardinal Health
12.4.9. NIHON KOHDEN CORPORATION
12.4.10. Vyaire Medical Inc.
Segments Covered in the Report
The global cardiopulmonary stress testing market has been segmented on the basis of
Application
The global cardiopulmonary stress testing market has been segmented on the basis of
Application
- Exercise Tolerance Testing Devices
- Echocardiograph Testing Devices
- Nuclear Stress Testing Devices
- Exercise Stress Testing Devices
- Pharmacological Stress Testing Devices
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Thermo Fisher Scientific Ltd
- Philips Healthcare
- Care Medical Ltd
- Cosmed Medical
- Cardiac Science Corporation
- GE Healthcare
- TouchPoint
- Cardinal Health
- NIHON KOHDEN CORPORATION
- Vyaire Medical Inc.
- W.L. Gore & Associates
Key players competing in the cardiopulmonary stress testing market are Thermo Fisher Scientific Ltd; Philips Healthcare; Care Medical Ltd; Cosmed Medical; Cardiac Science Corporation; GE Healthcare; TouchPoint; Cardinal Health; NIHON KOHDEN CORPORATION; Vyaire Medical Inc.; W.L. Gore & Associates.
Few of the industry's key players in the market are aggressively acquiring other firms to strengthen their market positions across the world, while some are introducing new products. Vyaire Medical Inc, for example, received FDA approval in August 2019 for its two Novel Pulmonary Function Testing Products, Vyntus ONE and Vyntus BODY, which extended their current Vyntus product line, which runs on the SentrySuite Software. The approved products offer a new ergonomic design as well as reliable and effective respiratory monitoring. The companies in the cardiopulmonary stress testing market are facing moderate level of competition.
Our Clients
Related Reports
Some other reports from this category!
